Back pain is the single leading cause of disability worldwide — affecting an estimated 619 million people globally as of 2020, a number projected to reach 843 million by 2050 (GBD 2021 Study, The Lancet Rheumatology, 2023). In the United States, 39% of adults reported back pain in the past three months, making it the most prevalent pain site in the country (CDC National Health Interview Survey, 2019). The total economic burden of low back pain in the U.S. alone has been estimated as high as $624.8 billion — more than the annual cost of cancer, heart disease, or diabetes (Lad et al., Spine, 2020). We aggregated data from the CDC National Center for Health Statistics, the Global Burden of Disease Study 2021, the Journal of Manipulative and Physiological Therapeutics, Chiropractic and Manual Therapies, and peer-reviewed systematic reviews to compile the most comprehensive picture of back pain prevalence, costs, and treatment outcomes available.
Key Takeaways
619 million people worldwide had low back pain in 2020 — projected to reach 843 million by 2050, a 36% increase (GBD 2021 Study, The Lancet Rheumatology, 2023)
39% of U.S. adults reported back pain in the past three months — the most prevalent pain site nationally (CDC NHIS, 2019)
28% of U.S. adults report chronic low back pain (National Survey of Children’s Health reference data, 2022, cited in multiple sources)
24.3% of U.S. adults experienced chronic pain of any kind in 2023, with 8.5% reporting high-impact chronic pain that limits life or work activities (CDC NCHS Data Brief No. 518, November 2024)
Low back pain is the leading cause of years lived with disability (YLD) globally — ranked number one worldwide (GBD 2021)
The total economic burden of low back pain in the U.S. has been estimated as high as $624.8 billion (Lad et al., Spine, 2020)
Spine-related pain costs the U.S. healthcare system an estimated $134.5 billion annually (Trager et al., Chiropractic and Manual Therapies, 2024)
Patients who chose a chiropractor as their first provider for spine-related pain incurred substantially lower downstream healthcare costs than those who started with medical management — including fewer opioid prescriptions, surgeries, and emergency department visits (Trager et al., Chiropractic and Manual Therapies, 2024)
Total cost of care was lowest when treatment began with a chiropractor ($5,093) versus an orthopedist ($9,434) — a 46% cost difference (BMC Health Services Research, 2022)
Lifetime prevalence of back pain reaches as high as 84% among adults worldwide (multiple systematic reviews)
Recurrence rates for low back pain within one year range from 24% to 80% (systematic review data)
Modifiable risk factors — occupational ergonomics, smoking, and high BMI — account for 38.8% of years lived with disability from low back pain (GBD 2021)
1. Back Pain Prevalence — How Common Is It Really?
Back pain is not an occasional inconvenience — it is one of the most pervasive health conditions on the planet. Nearly 4 in 10 U.S. adults reported back pain in the past three months, and across a lifetime, the majority of adults will experience at least one significant episode. What makes these numbers particularly striking is the persistence: up to 80% of people who experience low back pain will have a recurrence within a year. This isn’t a condition most people resolve and move on from — it’s one that cycles, compounds, and in many cases becomes chronic without effective structural intervention.
| Metric | Value | Source |
|---|---|---|
| People globally with low back pain (2020) | 619 million | GBD 2021 Study, The Lancet Rheumatology, 2023 |
| Projected global low back pain cases by 2050 | 843 million (+36%) | GBD 2021 Study, The Lancet Rheumatology, 2023 |
| U.S. adults reporting back pain in past 3 months | 39.0% | CDC NHIS, Lucas et al., NCHS Data Brief, 2021 |
| U.S. adults with chronic low back pain | ~28% | Multiple sources, 2022 data |
| U.S. adults with chronic pain of any kind (2023) | 24.3% | CDC NCHS Data Brief No. 518, November 2024 |
| U.S. adults with high-impact chronic pain (2023) | 8.5% | CDC NCHS Data Brief No. 518, November 2024 |
| Lifetime prevalence of back pain globally | Up to 84% | Multiple systematic reviews (most recent available) |
| 1-year recurrence rate for low back pain | 24%–80% | Systematic review data |
Recency note: The most current U.S. back pain site-specific prevalence data is from the 2019 NHIS. The CDC NCHS 2023 data (Data Brief No. 518) provides updated chronic pain totals but does not break out back pain specifically.
If you’re experiencing recurring or chronic back pain in the Plano, TX area, you’re not alone — and it’s not something you simply have to live with. Explore what our back pain chiropractic care approach looks like at Vita Nova.
2. The Economic Burden of Back Pain
Back pain is not just a health crisis — it’s a financial one. The gap between direct medical costs and the true economic burden of back pain is enormous, because the indirect costs — lost productivity, reduced earnings, disability claims, and workforce attrition — dwarf what shows up in healthcare spending figures. When researchers at Johns Hopkins analyzed the full economic impact of chronic pain, they found the total annual cost exceeds even cancer and heart disease combined. Back pain sits at the center of that burden. The single most impactful financial decision a back pain patient makes is who they see first.
| Metric | Value | Source |
|---|---|---|
| Total economic burden of LBP in U.S. (estimated high) | $624.8 billion | Lad et al., Spine, 2020 |
| Annual U.S. spine-related pain healthcare costs | $134.5 billion | Trager et al., Chiropractic and Manual Therapies, 2024 |
| Low back and neck pain — 3rd highest U.S. healthcare spending category | $87.6 billion | JAMA Health Care Spending Analysis (cited in APTA) |
| Annual cost of chronic pain in U.S. (total) | Up to $635 billion | Gaskin & Richard, Journal of Pain, 2012 — most recent comprehensive estimate available |
| Average annual healthcare cost — adults with back pain vs. without | $1,440 vs. $589 | Gaskin & Richard, Journal of Pain, 2012 |
| Workdays lost annually in U.S. due to back pain | ~83–186 million | Multiple occupational health sources (range reflects varying methodologies) |
| Share of LBP burden attributable to modifiable risk factors | 38.8% | GBD 2021 Study, The Lancet Rheumatology, 2023 |
Note on cost figures: Back pain economic burden estimates vary significantly across studies due to different methodologies for calculating indirect costs. The $624.8 billion figure (Lad et al.) represents the most comprehensive U.S.-specific estimate and includes indirect costs. The $134.5 billion figure (Trager et al.) refers specifically to spine-related healthcare spending. Both are cited in peer-reviewed literature.
3. Back Pain by Demographics — Who Is Most Affected
Back pain does not affect all populations equally. Age, sex, income, and geography all influence both prevalence and severity. The CDC data reveals a consistent pattern: back pain increases with age, disproportionately affects women and lower-income adults, and is highest in rural and less urbanized communities. Understanding who is most vulnerable matters for both individual prevention and healthcare resource allocation — and it underscores why accessible, community-based care like chiropractic is particularly important for under-resourced populations.
| Demographic | Back Pain Prevalence / Finding | Source |
|---|---|---|
| Adults aged 65 and over | Highest prevalence of any age group | CDC NHIS, Lucas et al., NCHS Data Brief, 2021 |
| Adults aged 45–64 | 44.3% reporting back pain | CDC NHIS 2019 |
| Adults aged 18–29 | 21.0% — demonstrating early onset | CDC NHIS 2019 |
| Women vs. men — chronic back pain | 41.3% of women vs. 34.3% of men report chronic back pain | National survey data, 2022 |
| Adults below 100% federal poverty level | Higher prevalence than those above 200% FPL (35.2%) | CDC NHIS 2019 |
| Non-Hispanic Asian adults | Lowest back pain prevalence (20.6%) | CDC NHIS 2019 |
| American Indian and Alaska Native adults | Highest high-impact chronic pain prevalence (12.7%) | CDC NCHS Data Brief No. 518, 2024 |
| Chronic pain prevalence — increases with decreasing urbanization | Higher in rural than urban populations | CDC NCHS Data Brief No. 518, 2024 |
4. Back Pain and Work — The Productivity Cost
Back pain is the second leading cause of missed work in the United States, behind only the common cold. But unlike a cold that resolves in days, back pain recurs — and for many workers it becomes a long-term constraint on productivity, career trajectory, and earnings. The occupational data reveals both the scale of the problem and the industries most exposed. What the research also shows is that early intervention and guideline-adherent treatment dramatically reduces lost workdays — making the choice of first provider one of the most consequential decisions a worker with back pain can make.
| Metric | Value | Source |
|---|---|---|
| Back pain — rank as cause of missed work | 2nd (behind common cold) | U.S. Bureau of Labor Statistics, occupational health literature |
| Working adults reporting back pain symptoms annually | ~50% | Multiple occupational health surveys |
| Workers with back pain missing ≥1 workday in past year | 64% vs. 45% without back pain | National survey data (most recent available) |
| Musculoskeletal disorders share of all industrial injuries (2020) | 30% | U.S. Bureau of Labor Statistics, 2020 |
| Healthcare workers — nursing assistants with musculoskeletal back injuries (2016) | 10,330 cases — among highest of any occupation | U.S. Bureau of Labor Statistics, 2016 |
| Workers treated according to evidence-based guidelines (2018) | 18% — up from 10% in 2009 | Hegmann et al., PLOS ONE, 2021 (California workers’ compensation data) |
| Low back pain — rank as cause of job-related disability | Leading cause | U.S. Bureau of Labor Statistics |
5. Chiropractic Care for Back Pain — What the Research Shows
The evidence base for chiropractic care for back pain is among the strongest in the chiropractic literature. Multiple systematic reviews have examined clinical outcomes and cost-effectiveness, and the most recent and comprehensive — a 2024 systematic review of 44 studies — reached a clear conclusion: patients who started with chiropractic care incurred lower overall costs and used fewer downstream healthcare services than those who started with medical management. This is not a fringe finding. It is consistent across studies of varying design and population.
| Finding | Detail | Source |
|---|---|---|
| Chiropractic as first provider — downstream cost outcome | Substantially decreased downstream healthcare costs vs. medical management | Trager et al., Chiropractic and Manual Therapies, 2024 (44-study systematic review) |
| Total cost of care — chiropractor first vs. orthopedist first | $5,093 vs. $9,434 (46% lower) | Molinari et al., BMC Health Services Research, 2022 |
| Total cost of care — chiropractor first vs. acupuncturist first | $5,093 vs. $9,205 | Molinari et al., BMC Health Services Research, 2022 |
| Opioid prescriptions — chiropractic first patients | Fewer than medically managed patients | Trager et al., Chiropractic and Manual Therapies, 2024 |
| Surgery and hospitalizations — chiropractic first patients | Fewer than medically managed patients | Trager et al., Chiropractic and Manual Therapies, 2024 |
| Emergency department visits — chiropractic first patients | Fewer than medically managed patients | Trager et al., Chiropractic and Manual Therapies, 2024 |
| Chiropractic vs. other conservative care for LBP clinical outcomes | Similar effects to physical therapy and medical care; no serious adverse events reported | Blanchette et al., PLOS ONE, 2016 (systematic review) |
| Spinal manipulation influence on inflammatory markers | Low-quality evidence that SMT influences biochemical/inflammatory markers including interleukins | Review cited in ChiroExcellence, 2024 |
Important context: The 2024 Trager et al. systematic review was limited primarily to retrospective cohort studies, which show association rather than causation. The consistency of findings across 44 studies of high or acceptable quality makes the pattern noteworthy, and researchers recommended further investigation with randomized designs to validate the trend.
At Vita Nova, Dr. Korrin uses the Zone Technique to address the neurological root of back pain — not just the structural symptom. Whether you’re dealing with lower back pain, sciatica, a disc herniation, or chronic back pain that has been building for years, a personalized care plan starts with understanding the root cause.
6. Future Projections — Where Back Pain Is Headed
The back pain crisis is getting worse, not better. Aging populations, increasingly sedentary lifestyles, rising obesity rates, and occupational demands are all converging to drive the global burden higher. The GBD 2021 projections are stark: 843 million people with low back pain by 2050 — a 36% increase from 2020. What the data also shows is that this trajectory is not inevitable. More than a third of the burden is attributable to modifiable risk factors, which means prevention and early conservative care have a meaningful role to play in changing the outcome.
| Metric | Value / Projection | Source |
|---|---|---|
| Global LBP cases projected by 2050 | 843 million (+36% from 2020) | GBD 2021 Study, The Lancet Rheumatology, 2023 |
| High-income North America LBP cases projected by 2050 | ~57 million | Statista, citing GBD projections, 2024 |
| Share of LBP burden from modifiable risk factors | 38.8% (occupational factors, smoking, high BMI) | GBD 2021 Study, The Lancet Rheumatology, 2023 |
| LBP in working-age population globally (2021) | 452.8 million cases — 52.66% increase since 1990 | Zhang et al., Frontiers in Public Health, 2025 |
| LBP global prevalence increase 1990–2020 (absolute numbers) | Significant increase despite declining age-standardized rates | GBD 2021 Study |
| LBP as leading cause of years lived with disability globally | Consistent ranking since first assessed in GBD studies | GBD 2021 Study, The Lancet Rheumatology, 2023 |
Back Pain by the Numbers — Summary Table
| Metric | Value | Source |
|---|---|---|
| People globally with low back pain (2020) | 619 million | GBD 2021, The Lancet Rheumatology, 2023 |
| Projected global LBP cases 2050 | 843 million | GBD 2021, The Lancet Rheumatology, 2023 |
| U.S. adults with back pain in past 3 months | 39.0% | CDC NHIS, NCHS Data Brief, 2021 |
| U.S. adults with chronic low back pain | ~28% | 2022 national survey data |
| U.S. adults with chronic pain (2023) | 24.3% | CDC NCHS Data Brief No. 518, 2024 |
| U.S. adults with high-impact chronic pain (2023) | 8.5% | CDC NCHS Data Brief No. 518, 2024 |
| Lifetime prevalence of back pain | Up to 84% | Multiple systematic reviews |
| 1-year recurrence rate for LBP | 24%–80% | Systematic reviews |
| Total U.S. economic burden of LBP | Up to $624.8 billion | Lad et al., Spine, 2020 |
| Annual U.S. spine-related healthcare costs | $134.5 billion | Trager et al., Chiropractic and Manual Therapies, 2024 |
| Cost of care — chiropractor first vs. orthopedist first | $5,093 vs. $9,434 | Molinari et al., BMC Health Services Research, 2022 |
| Chiropractic first — downstream services comparison | Fewer opioids, surgeries, ER visits, hospitalizations | Trager et al., Chiropractic and Manual Therapies, 2024 |
| Share of LBP burden from modifiable risk factors | 38.8% | GBD 2021, The Lancet Rheumatology, 2023 |
| Women vs. men — chronic back pain prevalence | 41.3% vs. 34.3% | National survey data, 2022 |
| LBP global disability rank | #1 cause of years lived with disability | GBD 2021 |
Methodology and Sources
All statistics in this article were sourced from Tier 1 primary research — government health surveys, peer-reviewed systematic reviews, and published clinical studies. Where secondary sources were referenced for context, the underlying primary study is cited. No statistics were taken from secondary blogs or unattributed roundups.
- GBD 2021 Collaborators. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050. The Lancet Rheumatology. 2023. PMC10234592
- Lucas JW, Sohi I et al. Chronic Pain and High-impact Chronic Pain in U.S. Adults, 2023. CDC NCHS Data Brief No. 518, November 2024. CDC NCHS
- Lucas JW, Connor EM, Bose J. Back, Lower Limb, and Upper Limb Pain Among U.S. Adults, 2019. CDC NCHS Data Brief No. 415, July 2021. CDC NCHS
- Trager RJ et al. Cost of chiropractic versus medical management of adults with spine-related musculoskeletal pain: a systematic review. Chiropractic and Manual Therapies. 2024;32:8. PMC10918856
- Molinari RW et al. Where to Start? A Two Stage Residual Inclusion Approach to Estimating Influence of the Initial Provider on Health Care Utilization and Costs for Low Back Pain in the US. BMC Health Services Research. 2022;22(1):694. PMID: 35606836
- Lad SP et al. Healthcare Resource Utilization and Management of Chronic, Refractory Low Back Pain in the United States. Spine. 2020;45(20):E1333–E1341. PMC8875812
- Blanchette MA et al. Effectiveness and Economic Evaluation of Chiropractic Care for the Treatment of Low Back Pain: A Systematic Review of Pragmatic Studies. PLOS ONE. 2016. PLOS ONE
- Gaskin DJ, Richard P. The Economic Costs of Pain in the United States. Journal of Pain. 2012;13(8):715–724. NCBI Bookshelf
- Zhang C et al. Global, regional, and national burden of low back pain in working-age population from 1990 to 2021 and projections for 2050. Frontiers in Public Health. 2025. PMC12058504
- Hegmann KT et al. Guideline adherence and lost workdays for acute low back pain in the California workers’ compensation system. PLOS ONE. 2021.
- U.S. Bureau of Labor Statistics. Occupational injury and illness data. Various years. BLS.gov
Last updated: April 2026. This page is reviewed and updated as new primary research becomes available.
If back pain is affecting your quality of life, work, or sleep, the most important step is understanding what’s actually driving it. At Vita Nova Chiropractic in Plano, TX, Dr. Korrin evaluates the structural and neurological root of your pain and builds a personalized care plan around lasting relief. Schedule your first visit today.
